Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study

Go back to Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
(NASDAQ: DTIL) Delayed: 8.46 -0.39 (4.41%)
Previous Close $8.85    52 Week High
Open $8.82    52 Week Low
Day High $8.82    P/E N/A 
Day Low $8.41    EPS
Volume 152,284